Eziafa Oduah, Scott Joseph Antonia, Jeffrey J. Clarke, Tom Stinchcombe, Joel Rivera Concepcion, Laura Alder, Cameron Oswalt, Thomas A. D'Amico, David H. Harpole, Betty Caroline Tong, Hai Salfity, Kunal Patel, Kaitlin Bevers, Matthew Galen Hartwig, Xiaofei F. Wang, Neal E. Ready. "Safety, efficacy, and tumor immune microenvironment changes with neoadjuvant chemotherapy and cemiplimab with or without alirocumab in stage 1B-3A non-small cell lung cancer.." Journal of Clinical Oncology (2025). https://doi.org/10.1200/jco.2025.43.16_suppl.tps8118